Call me crazy, but when it comes to products that could so easily cause death, a barrier to entry is a good thing.
Call me crazy, but when it comes to products that could so easily cause death, a barrier to entry is a good thing.
The problem with regulatory capture and arguing it's a good thing, is that there's a downside/cost to the barrier it creates. And often that downside outweighs the upside.
To be clear, no one is arguing regulation shouldn't exist. Just that the nature of regulation is to be captured by incumbents and serve a purpose orthogonal to protecting the people.
I can't speak for insulin injectors, but I know for a fact that the reason Indian pharmaceuticals are often times massively cheaper is because they ignore patents by which the majority of the world abides.
Now in many cases, the patent system is set up for incumbents who have enough legal muscle to develop and patent isomers, metabolites, or "extended release" versions of successful drugs which are losing their patent privileges. But that's not the whole story. We know that some patents and copyrights are needed to encourage investment in R&D.
India (used to?) just blindly copy drugs, ignore paying royalties, and take the profits. I haven't ever been on any blockbuster meds developed natively in India. Have you?
(I’m actually fairly bearish on level 5 self-driving being “close”, but if it was, speeding that up would almost surely be worth throwing the switch on the trolley tracks for both the lives saved and the reduction in wasted attention of those who would have otherwise used a lot of their lifetime driving.)